Skip to the page

Data / Form D filings / MIRACULINS INC

MIRACULINS INC: Form D filings

MIRACULINS INC, a biotechnology company in Winnipeg, Manitoba, Canada, filed 3 Form D notices with the SEC between 2013 and 2015. The latest, on May 1, 2015, reports $20,408 sold of a $51,019 offering to 1 investor.

Find out what MIRACULINS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6-1250 WAVERLEY STREET, Winnipeg, Manitoba, Canada, R3T 6
Phone
(204) 453-1408
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Canada (Federal Level)
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1584322

The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 1, 2015New notice$51,019$20,408$30,6111Apr 22, 2015sec.gov
Jan 5, 2015New notice$215,025$0$215,0251Dec 23, 2014sec.gov
Aug 13, 2013New notice$2,247,354$888,716$1,358,6381Jul 31, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
L. MICHAEL COUTTSExecutive Officer
WILLIAM J.F. ROBERTSDirector
HARRY J.F. BLOOMFIELDDirector
JAMES J.F. KINLEYExecutive Officer
P. MARCUS J.F. ENNSExecutive Officer
MICHAEL J.F. EVELEGHExecutive Officer
PAUL J.F. MOREAUExecutive Officer
CHRISTOPHER J MOREAUExecutive Officer, Director
MICHAEL J.F. STASIUKDirector

Every Form D from the week of Apr 27, 2015 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what MIRACULINS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.